All sponsors

GI Innovation, Inc.

Clinical trial pipeline · active industry-sponsored Phase 1/2 to Phase 3 trials · updated 2026-11-13
ACTIVE TRIALS5
PHASE 3 / 2-30
RECRUITING5
READOUTS ≤12 MONTHS1
Open GI Innovation, Inc. on the live radar map →
TRIALPHASESTATUSCONDITIONNPRIMARY COMPLETION
GI-102 subcutaneous (SC)
NCT05824975
P1/2RecruitingAdvanced Solid Tumor; Metastatic Solid Tumor3582025-11-12
GIANTS-1
NCT07363057
P2RecruitingCancer Survivors; Healthy Participant152026-05
GI-108
NCT07172802
P1/2RecruitingAdvanced Solid Tumor; Metastatic Solid Tumor1022027-02
GI-101
NCT04977453
P1/2RecruitingAdvanced Solid Tumor; Metastatic Solid Tumor3172028-06-30 (+34 mo)
GI-102
NCT07871435
P1/2RecruitingMetastatic Castration-resistant Prostate Cancer (mCRPC)1072029-03-31